Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:10 PM
Study NCT ID:
NCT04957758
Status:
COMPLETED
Last Update Posted:
2024-05-07
First Post:
2021-06-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
Sponsor:
Oyster Point Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-28
First Submit QC Date:
None
Study First Post Date:
2021-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-08
Results First Submit QC Date:
None
Results First Post Date:
2024-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-11
Last Update Post Date:
2024-05-07
Last Update Post Date Type:
ACTUAL